Targeted Therapies for NSCLC: Where Are We Today?

Are you up to date with therapy strategies for ALK translocation and EGFR mutation–positive non-small cell lung cancer?

Credit available for this activity expires: 9/10/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002896?ecd=bdc_podcast_libsyn_mscpedu